Skip to main content
Discovering the causes of cancer and the means of prevention
 

Erping Long, M.D., Ph.D., joined the Laboratory of Translational Genomics (LTG) as a postdoctoral fellow in the laboratory of Jiyeon Choi, Ph.D., M.S., Earl Stadtman investigator, in 2021. Dr. Long completed his M.D., Ph.D. in Clinical Medicine (Ophthalmology) from Zhongshan Ophthalmic Center, Sun Yat-sen University, China in 2020 (Mentors: Drs. Yizhi Liu and Haotian Lin). His thesis focused on translating artificial intelligence into clinical benefits for visually impaired infants. Dr. Long conducted an independent part of his doctoral research at the University of Michigan, Ann Arbor, where he worked with Dr. Jianzhi Zhang on how evolutionary force shapes the genetic risk of human senescence and disease. He was one of 10 recipients awarded the Ray Wu Prize in 2020.

Dr. Long conducts research that leverages computational approaches and large-scale functional genomics resources to understand genetic susceptibility to lung cancer and melanoma, under the mentorship of Dr. Choi, and Mitchell Machiela, Sc.D., M.P.H., Earl Stadtman Investigator, Integrative Tumor Epidemiology Branch.